These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 14734685)

  • 21. Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study.
    Weinberg AD; Thalhofer C; Morris N; Walker JM; Seiss D; Wong S; Axthelm MK; Picker LJ; Urba WJ
    J Immunother; 2006; 29(6):575-85. PubMed ID: 17063120
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Pfannkuchen N; Bausbacher N; Pektor S; Miederer M; Rosch F
    Curr Radiopharm; 2018; 11(3):223-230. PubMed ID: 29866026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
    Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
    J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with
    Kratochwil C; Bruchertseifer F; Rathke H; Bronzel M; Apostolidis C; Weichert W; Haberkorn U; Giesel FL; Morgenstern A
    J Nucl Med; 2017 Oct; 58(10):1624-1631. PubMed ID: 28408529
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Jiang Z; Revskaya E; Fisher DR; Dadachova E
    Curr Radiopharm; 2018; 11(3):215-222. PubMed ID: 29683101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.
    Henriksen G; Schoultz BW; Michaelsen TE; Bruland ØS; Larsen RH
    Nucl Med Biol; 2004 May; 31(4):441-9. PubMed ID: 15093814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
    Jaggi JS; Seshan SV; McDevitt MR; Sgouros G; Hyjek E; Scheinberg DA
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1503-12. PubMed ID: 16503385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus.
    Tijink BM; Buter J; de Bree R; Giaccone G; Lang MS; Staab A; Leemans CR; van Dongen GA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6064-72. PubMed ID: 17062682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates.
    Fishwild DM; Hudson DV; Deshpande U; Kung AH
    Clin Immunol; 1999 Aug; 92(2):138-52. PubMed ID: 10444358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution and biological effects of inhaled 239Pu(NO3)4 in cynomolgus monkeys.
    Brooks AL; Guilmette RA; Hahn FF; Haley PJ; Muggenburg BA; Mewhinney JA; McClellan RO
    Radiat Res; 1992 Apr; 130(1):79-87. PubMed ID: 1561321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
    Chen P; Wang J; Hope K; Jin L; Dick J; Cameron R; Brandwein J; Minden M; Reilly RM
    J Nucl Med; 2006 May; 47(5):827-36. PubMed ID: 16644753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas.
    Torres LA; Coca MA; Batista JF; Casaco A; Lopez G; García I; Perera A; Peña Y; Hernández A; Sanchez Y; Romero S; Leyva R; Prats A; Fernandez R
    Nucl Med Commun; 2008 Jan; 29(1):66-75. PubMed ID: 18049099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.
    Sgouros G; Ballangrud AM; Jurcic JG; McDevitt MR; Humm JL; Erdi YE; Mehta BM; Finn RD; Larson SM; Scheinberg DA
    J Nucl Med; 1999 Nov; 40(11):1935-46. PubMed ID: 10565792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
    Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
    Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.